Your session is about to expire
← Back to Search
Cardiac Telerehabilitation for Heart Disease
N/A
Waitlist Available
Led By Nitin G Vaswani, MD
Research Sponsored by NODEHealth Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trial looks at the effectiveness of an online CR platform to engage patients in CR while remaining safe. The platform provides remote access, digital tools, and feedback between patients and experts.
Who is the study for?
Adults aged 45 or older with heart conditions like angina, coronary artery disease, or a recent heart attack who've been referred to cardiac rehab (CR) can join. They must be able to walk, stable under medical care, and at low-to-moderate risk of exercise-related heart problems. Excluded are those severely overweight, recently hospitalized, unable to use smartphones/tablets for the program, without WIFI/email access, or have hearing/sight issues that prevent following instructions.Check my eligibility
What is being tested?
The study is testing the RecoveryPlus platform for cardiac telerehabilitation (CTR). It aims to see if this digital tool helps patients engage more in CR exercises from home compared to traditional in-person sessions. The trial will monitor how well participants start and stick with their exercise programs using this technology.See study design
What are the potential side effects?
Since this trial involves an exercise program delivered through a digital platform rather than medication or invasive procedures, side effects may include typical risks associated with physical activity such as muscle soreness or strain but should otherwise be minimal.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
INITIATION
PARTICIPATION
SAFETY
+1 moreSecondary outcome measures
6-minute WALK TEST
QUALITY OF LIFE
RESTING HEART RATE
Trial Design
1Treatment groups
Experimental Treatment
Group I: Cardiac Telerehabilitation ArmExperimental Treatment1 Intervention
In this prospective, single-arm study, we will look at the initiation, participation, sustained engagement, and safety of 100 adult subjects (ages 45 years or older) with recent (within the past 60 days) clinician referral to CR who are offered CTR via the RecoveryPlus platform.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cardiac Telerehabilitation (CTR) via the RecoveryPlus platform
2023
N/A
~80
Find a Location
Who is running the clinical trial?
NODEHealth FoundationLead Sponsor
Nitin G Vaswani, MDPrincipal InvestigatorNODEHealth Foundation
1 Previous Clinical Trials
10,000 Total Patients Enrolled
Media Library
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still room for participation in this research study?
"Per the latest clinicaltrials.gov information, this medical trial is actively recruiting patients. It was initially advertised on 3/27/2023 and has been updated as of that same date."
Answered by AI
What is the numerical scope of participants for this trial?
"Yes, clinicaltrials.gov confirms that recruitment for this scientific investigation is still underway since its initial posting on March 27th 2023 and most recent update. As such, 100 study participants are needed from a single research centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger